| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.017 | 0.7 |